Short Interest in MediPharm Labs Corp. (OTCMKTS:MEDIF) Decreases By 78.5%

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totaling 34,298 shares, a decline of 78.5% from the April 30th total of 159,517 shares. Based on an average daily volume of 188,139 shares, the short-interest ratio is currently 0.2 days.

MediPharm Labs Stock Performance

OTCMKTS:MEDIF traded up $0.00 during trading hours on Friday, hitting $0.06. The company’s stock had a trading volume of 18,776 shares, compared to its average volume of 88,020. MediPharm Labs has a 52-week low of $0.04 and a 52-week high of $0.08. The stock has a fifty day moving average of $0.05 and a 200-day moving average of $0.05.

About MediPharm Labs

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.